Strides Shasun
9.85 (0.91%) 8.75 (0.81%) - Quote
- CHARTS
- NEWS
- COMMENTS
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
12.00 pm | 24 Jul 2017 | Source: Moneycontrol.com
The product will be manufactured at the company's flagship facility at Bangalore and marketed by Strides Pharma, Inc in the US market....
8.58 am | 24 Jul 2017 | Source: Moneycontrol.com
Strides Shasun has received approval from United States Food & Drug Administration (USFDA) for Cetirizine Hydrochloride capsules, 10 mg....
8.15 am | 24 Jul 2017 | Source: Moneycontrol.com
According to Prakash Gaba of prakashgaba.com, the next logical technical target for the Nifty is at 9969. The crucial support for the Index is at 9792...
12.33 pm | 17 Jul 2017 | Source: CNBC-TV18
Strides Shasun may receive approval for Lovaza generic, which has a market size of around USD 750-800 million in the United Sates and could make upto ...
2.26 pm | 03 Jul 2017 | Source: CNBC-TV18
Competition Commission of India (CCI) approves Scheme of Arrangement between Strides Shasun, Sequent Scientific and Solara Active Pharma Sciences. In ...
11.45 am | 03 Jul 2017 | Source: PTI
The product will be manufactured at the company's Bengaluru facility and marketed by Strides Pharma Inc in the US market....
9.29 am | 03 Jul 2017 | Source: Moneycontrol.com
The company has received approval from the United States Food & Drug Administration (USFDA) for Promethazine Hydrochloride tablets USP, 12.5 mg, 25 mg...
8.50 am | 03 Jul 2017 | Source: Moneycontrol.com
Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Promethazine Hydrochloride Tablets USP, 12.5 mg, 25...
1.39 pm | 27 Jun 2017 | Source: Moneycontrol.com
Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1,200 in its research report dated Jun 22, ...
11.03 am | 22 Jun 2017 | Source: Moneycontrol.com
Strides Shasun has signed definitive agreements with Vivimed Lab....
1.52 pm | 20 Feb 2017 | Source: Moneycontrol.com
Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1340 in its research report dated February ...
2.30 pm | 07 Feb 2017 | Source: CNBC-TV18
Going forward, the pharma company is going to to focus on its B2C business and the high cash generating verticals, he says....
2.46 pm | 03 Feb 2017 | Source: Moneycontrol.com
Bangalore-based Healthcare firm Strides Shasun has reported a massive 3-fold jump in third quarter consolidated profit at Rs 187.3 crore compared with...